Vilya Company
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Total Funding:
50000000.0
Headquarters:
Seattle, Washington, United States
Funding Status:
Early Stage Venture
Last Funding Type:
Series A
Last Funding Date:
2022-08-29
Investors Number:
1.0
Founded Date:
2022-01-01
Industry:
Early Drug Development